XML 25 R8.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2022
Operating activities      
Net income $ 106,719 $ 174,887 $ 268,318
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 129,002 133,793 129,107
Equity in net loss (income) of unconsolidated affiliates 295 (16,068) (23,505)
Deferred income taxes (122,573) 71,403 56,792
Stock-based compensation 23,290 13,734 46,229
Impairment of assets 140,053 56,718 18,829
Gain on FFF Put and Call Rights 0 0 (64,110)
Other, net (4,518) 6,501 5,803
Changes in operating assets and liabilities, net of the effects of acquisitions:      
Accounts receivable (11,399) 477 27,318
Contract assets (39,265) (41,088) (47,219)
Inventory (2,867) 42,720 56,724
Prepaid expenses and other assets (5,920) 21,056 40,617
Accounts payable 8,717 7,415 (41,184)
Revenue share obligations 30,504 16,893 18,512
Accrued expenses, deferred revenue and other liabilities 44,522 (43,898) (47,997)
Net cash provided by operating activities 296,560 444,543 444,234
Investing activities      
Purchases of property and equipment (81,189) (82,302) (87,440)
Sale of investment in unconsolidated affiliates 12,753 0 0
Acquisition of businesses and equity method investments, net of cash acquired 0 (187,750) (26,000)
Investment in unconsolidated affiliates (30) (2,060) (16,000)
Other 0 (1,510) (10,000)
Net cash used in investing activities (68,466) (273,622) (139,440)
Financing activities      
Payments on notes payable (100,937) (100,859) (99,243)
Proceeds from credit facility 0 470,000 325,000
Payments on credit facility (215,000) (405,000) (250,000)
Proceeds from sale of future revenues 681,427 0 0
Payments on liability related to the sale of future revenues (31,535) 0 0
Cash dividends paid (95,207) (100,233) (96,455)
Repurchase of Class A common stock (400,000) 0 (250,129)
Payments on deferred consideration related to acquisition of business (27,187) (27,927) (28,586)
Proceeds from exercise of stock options under equity incentive plan 0 6,078 37,766
Other, net (4,281) (9,325) 13,858
Net cash used in financing activities (192,720) (167,266) (347,789)
Effect of exchange rate changes on cash flows (21) (5) (3)
Net increase (decrease) in cash and cash equivalents 35,353 3,650 (42,998)
Cash and cash equivalents at beginning of period 89,793 86,143 129,141
Cash and cash equivalents at end of period $ 125,146 $ 89,793 $ 86,143